A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population—The MiCheck-01 prospective trial-Reference-Cited by-同舟云学术

A comparison of prostate health index, total PSA, %free PSA, and proPSA in a contemporary US population—The MiCheck-01 prospective trial

Published:2020-08 Issue:8 Volume:38 Page:683.e1-683.e10
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Shore Neal D.,Pieczonka Christopher M.^ORCID,Henderson R. Jonathan^ORCID,Bailen James L.,Saltzstein Daniel R.,Concepcion Raoul S.,Beebe-Dimmer Jennifer L.,Ruterbusch Julie J.,Le Thao Ho^ORCID,Levin Rachel A.,Wissmueller Sandra,Prah Philip,Borotkanics Robert^ORCID,Paivanas Thomas A.,van Breda Arletta,Campbell Douglas H.,Walsh Bradley J.^ORCID

Funder

Minomic International Ltd

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference31 articles.

1. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019

2. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes — results from the SEARCH database;Freedland;Eur Urol,2008

3. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate;Stamley;N Engl J Med,1987

4. Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression o;Lieberman;Am J Ther,2004

5. Prostate-specific antigen in serum occurs predominantly in complex with a.1-antichymotrypsin;Lilja;Clin Chem,1991

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and evaluation of the MiCheck® Prostate test for clinically significant prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-11

2. Circulating Tumor Cells in Men Treated for Prostate Cancer;Circulating Tumor Cells;2023

3. New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index;The Prostate;2022-08-16

4. Índice de Salud Prostática (phi);Medicina y Laboratorio;2022-01-11

5. A Machine Learning-Driven Approach to Predict the Outcome of Prostate Biopsy: Identifying Cancer, Clinically Significant Disease, and Unfavorable Pathological Features on Prostate Biopsy;Advances in Computer Vision and Computational Biology;2021